Mezlocillin and azlocillin: an evaluation of two new beta-lactam antibiotics. 1979

C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley

Mezlocillin and azlocillin are broad spectrum penicillins for parenteral administration. In this study it was shown that they were very active against a wide range of pathogenic bacteria. Thirty-five patients were treated with mezlocillin, and 5 patients were treated with azlocillin (in combination with cefoxitin in 3 cases). The serum, bile and CSF levels of the drugs were measured. Both antibiotics would appear to be safe and efficacious in treating serious infections by sensitive pathogens. Infections caused by unknown pathogens could be treated by one of these agents in combination with a broad spectrum beta-lactamase stable cephalosporin or cephamycin.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D002228 Carbenicillin Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. Carboxybenzyl Penicillin,Anabactyl,Carbapen,Carbecin,Carbenicillin Disodium,Geopen,Microcillin,Pyopen,Disodium, Carbenicillin,Penicillin, Carboxybenzyl
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
January 1986, Reviews of infectious diseases,
C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
May 1982, Medicina clinica,
C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
June 1978, Antimicrobial agents and chemotherapy,
C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
January 1977, Infection,
C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
May 1983, The Journal of antimicrobial chemotherapy,
C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
January 1980, Acta clinica Belgica,
C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
January 1979, Arzneimittel-Forschung,
C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
May 1978, Antimicrobial agents and chemotherapy,
C J Ellis, and A M Geddes, and P G Davey, and R Wise, and J M Andrews, and R P Grimley
March 1981, Orvosi hetilap,
Copied contents to your clipboard!